COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial.

@article{Khor2007COX2EP,
  title={COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial.},
  author={Li-Yan Khor and Kyounghwa Bae and Alan S. Pollack and M Elizabeth Hale Hammond and David J. Grignon and Varagur Mohan Venkatesan and SethA. Rosenthal and Mark A. Ritter and Howard Martin Sandler and Gerald E. Hanks and William U. Shipley and Adam P Dicker},
  journal={The Lancet. Oncology},
  year={2007},
  volume={8 10},
  pages={
          912-20
        }
}
BACKGROUND COX-2 is overexpressed in some cancers, including prostate cancer; however, little is known about the effect of COX-2 overexpression on outcome in radiation-treated patients with prostate cancer. We aimed to study COX-2 overexpression and outcome in a well-defined cohort of men who received treatment with short-term androgen deprivation (STAD) plus radiotherapy or long-term androgen deprivation (LTAD) plus radiotherapy. METHODS Men with prostate cancer who had participated in the… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 45 CITATIONS

Similar Papers

Loading similar papers…